The oral antidiabetic drug metformin (dimethylbiguanide) improves insulin sensitivity primarily via its metabolic actions and is the cornerstone of pharmaco-therapy in type 2 diabetes mellitus [18]. The gene discussed is INS; the disease is diabetes mellitus.